chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Corneal reflex decreased
Clinical narrative: I asked which arms does the mom want the mom stated one in each.  Left arm flu shot coming ok. I wanted her to breath deeper and encouraged her to breath deeper .  I was encouraging the daughter to breath more deeper.  This is my standard procedure with administering the shots and then mom said the shots do not bother her and she is handling them well.  Mom stated to give the other one so I proceeded to administer the give to the right arm. So when i finished placed the safety cap on the needle mom started to calling her name loud and something is happening to her.  So I bent over to her to see what is going on and see did not blink her eyes.   She asked for the water and  went then to pharmacy and heard in the mean time mom raising her voice because she was not able to moving and I  told the pharmacy manager to call 911.  He called I went back into the room and we were encouraging the daughter to stay with us.  the pharmacy manager got the head set with 911 operator on phone and attempted unsuccessfully to administer the epipen in the left thigh.   The paramedics were on the way and the operator was on the phone the whole time until paramedics showed up and took over.  We did place the daughter on the floor and monitored here breathing and legs bent and she came more around too.  Then paramedics arrived and worked on her.  The patient was conscious and walked to the stretcher with assistance and taken to the hospital with the Mom going with her
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Injection site pain, Melaena
Clinical narrative: Arm pain at site of injection, progressing in intensity.  Mild dizziness.  Dark, tarry stool.
Age: 15.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Incorrect route of product administration, Pain of skin, Skin reaction, Swelling
Clinical narrative: Local angry skin reaction due to subcutaneous injection instead of intramuscular. Painful, red, swollen 35 hours later.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Skin irritation, Urticaria
Clinical narrative: Ever since I got the vaccine, I have had persistent hives with skin irritation. The symptoms appear for a couple months, then disappear for a month or two. The intensity varies.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Bone pain, Injection site pain, Pain
Clinical narrative: Patient said he feels deep seated, sharp shooting pain where the needle was put into the arm. His bone aches. It is periodic, random, not excruciating. It is internal not external. It does not occur every day.
Age: 73.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: The patient received a dose of arexvy 11/16/23 and again 11/29/24. Per guidelines should have only received one dose once.
Age: 71.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Dizziness, Mobility decreased, Peripheral swelling, Seizure, Unresponsive to stimuli
Clinical narrative: Swollen, red arm that patient states was worse than normal with vaccines. Patient states she experienced a seizure on the day following vaccine administration. She was dizzy, unable to move, could hear people speak to her but was unable to respond. Patient states that this lasted for about 10 seconds and has not recurred. Patient does not have history of seizures. Patient consulted with her primary care physician over the phone. Her doctor did not believe she required follow-up at this time and advised her to monitor for recurrence.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Nausea, Pallor, Syncope
Clinical narrative: Patient had a syncopal episode in clinic after administration of Covid-19 Comirnaty Pfizer 2024-2025 vaccine. Patient's parent was present and denies any syncopal episodes in the past. Parent does report patient has received Covid vaccines without any incident prior to this episode. Within 30 seconds of administration, patient began to report nausea, became pale and then lost consciousness for about 5 seconds. Patient was in a chair at the time of the episode and was supported by provider and patient's mother. Once patient was alert and feeling able to ambulate, she was moved to the exam table and laid down. She was given water and vital signs were checked. All vital signs were within normal parameters on assessment. Patient was alert and oriented to self, her surroundings and the situation, but did report feeling weak and a little disoriented. Within 15 minutes after administration of vaccine, patient was feeling well enough to ambulate with standby assistance to her parent's vehicle and was driven home. Call was placed to patient's parent 2 hours after patient left the clinic and parent reports patient is feeling much better.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Extrasystoles, Fatigue, Impaired work ability
Clinical narrative: 3-4 days later: fatigue, skipped beats. History of covid end June 2024. Was >90 days at vaccine receipt. Immune compromised on Stelara. Progressive worsening of symptoms. Hospitalized on 11/20/24 with palpitations, shortness of breath. Discharged on 11/21/24. Medical LOA 11/21/24 to 12/6/2024
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Scan myocardial perfusion
Clinical narrative: 3-4 days later: fatigue, skipped beats. History of covid end June 2024. Was >90 days at vaccine receipt. Immune compromised on Stelara. Progressive worsening of symptoms. Hospitalized on 11/20/24 with palpitations, shortness of breath. Discharged on 11/21/24. Medical LOA 11/21/24 to 12/6/2024
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: pt complained of pain in shoulder and inability to move arm within 6 hours of receiving the vaccine. she took a single dose of tylenol to help with discomfort. she waited 21 days to come back to pharmacy to make a complaint and receive medical advice. at this point she was able to move her arm over her head but complained of lingering pain especially when sleeping on that shoulder. I advised starting ibuprofen at night with food and tylenol during the day, stretching and motion exercises, and heat therapy (initially advised pt to seek medical attention from md but she refused - she's a nurse from another country) - we agreed that she would try these treatments for 7 days and return for further assessment / md referral. pt believes this was a bursa type injury due to high shot placement on arm.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Dyspnoea, Electrocardiogram, Fatigue
Clinical narrative: extreme fatigue, and difficult breathing, even after a week and still on going. of Nov. 30 2024
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Aldolase normal, Amino acid level, Antibody test negative, Antineutrophil cytoplasmic antibody negative, Antinuclear antibody negative
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Arteriosclerosis coronary artery, Blood arsenic normal, Blood copper, Blood creatine phosphokinase increased, Blood folate normal
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Blood glucose normal, Blood homocysteine normal, Blood lead normal, Blood mercury normal, Blood sodium decreased
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Blood thyroid stimulating hormone decreased, C-reactive protein normal, CSF glucose increased, CSF pressure normal, CSF protein increased
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: CSF red blood cell count positive, CSF volume, CSF white blood cell count negative, Computerised tomogram head normal, Computerised tomogram spine abnormal
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Cortisol normal, Diabetic neuropathy, Electrophoresis protein normal
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Fall, Gait inability, Glycosylated haemoglobin normal, Gram stain, Gram stain negative
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Guillain-Barre syndrome, Headache, Hypoaesthesia, Hyponatraemia, Immunoglobulin therapy
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Inappropriate antidiuretic hormone secretion, Intervertebral disc protrusion, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal abnormal, Muscular weakness
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Neuralgia, Paraesthesia, Red blood cell sedimentation rate increased, Scan with contrast abnormal, Spinal osteoarthritis
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Spinal stenosis, Treponema test negative, Vertebral foraminal stenosis, Vitamin B12 normal, White blood cell count normal
Clinical narrative: Vaccination administered at Health Center on 11/06/2024. On 11/19/2024 patient developed progressively worsening bilateral leg weakness/numbness/tingling, bilateral arm neuropathic pain, and headaches resulting in 4 falls over 2 days. He was evaluated in our clinic on 11/21/2024 and prescribed a trial of duloxetine and gabapentin for what was presumed to be worsening of his known diabetic neuropathy though this was thought to be unusual given point-of-care A1c on that date was 6.4%. Symptoms worsened despite prescribed medications and patient was brought to Hospital ED for evaluation on 11/22/2024. At this point he was unable to walk at all due to his leg weakness and bilateral leg numbness. He was thought to have some kind of nerve impingement issue wand was admitted to the hospital for further evaluation. Workup for a broad differential diagnosis including  polymyalgia rheumatica, giant cell arteritis, Guillain-Barré syndrome, vitamin B12 deficiency, folate deficiency, MS, cervical spondylitis myelopathy, ALS, hypothyroidism, spinal cord pathology, and/or worsening diabetic neuropathy was initiated. Ultimately, in consultation with multiple neurologists, patient was diagnosed with Guillain-Barré syndrome based on labs and imaging. Hospitalization has been complicated by persistent hyponatremia secondary to SIADH due to Guillain-Barré syndrome. Patient was started on a 5 day course of IVIG 11/26/2024-11/30/2024 with minor improvement to his motor symptoms and nerve pain however he remains unable to walk.  He remains hospitalized and the current plan is for the patient to undergo plasmapheresis inpatient followed by an extended stay at an acute rehabilitation facility for PT/OT. Per neurology, patient may possibly never regain his ability to walk.
Age: 1.17
Sex: M
Vaccine: UNK, UNK, UNK, UNK
Symptoms: Attention deficit hyperactivity disorder, Autism spectrum disorder, Developmental delay, Pyrexia, Sensory processing disorder
Clinical narrative: In 2011 after receiving several vaccinations and a flu shot. My son nearly died. Had a fever of 107 and was hospitalized in a bubble for nearly a week. The doctors exact words to me was "Mom, you dodged a bullet. Babies don't make it through what your son went through." After being released from the hospital I began to notice challenges with his development and was referred to a Dr. to be evaluated. He was diagnosed as having ADHD at that time. Further evaluation diagnosed as having sensory processing disorder and  being on the autistic spectrum.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram, Fatigue, Pericarditis, Pyrexia
Clinical narrative: Premature ventricular contractions, chest pain, fatigue, low grade fever, likely pericarditis
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Ventricular extrasystoles
Clinical narrative: Premature ventricular contractions, chest pain, fatigue, low grade fever, likely pericarditis
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Diarrhoea, Dizziness, Gait disturbance, Mobility decreased, Nausea
Clinical narrative: Intense and incredible vertigo, dizziness , nausea , vomiting , diarrhea , unable to walk without support , unable to get out of bed for 3 days.
Age: 71.0
Sex: F
Vaccine: UNK
Symptoms: Vertigo, Vomiting
Clinical narrative: Intense and incredible vertigo, dizziness , nausea , vomiting , diarrhea , unable to walk without support , unable to get out of bed for 3 days.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac monitoring, Dizziness, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: Racing heartbeat.  Numerous EKGs reporting possible Atrial Fibrillation.  Light headedness.  Shortness of breath while NOT exerting at all.  All started after second vaccine shot.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Racing heartbeat.  Numerous EKGs reporting possible Atrial Fibrillation.  Light headedness.  Shortness of breath while NOT exerting at all.  All started after second vaccine shot.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling, Pyrexia, Tinnitus
Clinical narrative: Swollen arm, aches, fever, recurring tinnitus
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain
Clinical narrative: Severe chills, severe pain at injection site, headache
Age: 34.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Dysstasia, Gait disturbance, Muscular weakness, Walking aid user
Clinical narrative: Approximately 8 hours after vaccines I experienced sudden weakness in my legs. After resting for about 10 mins I was not able to get up and walk without assistance. I am on day 6 of using a walker and still have not made any recovery.
Age: 0.33
Sex: M
Vaccine: DTAP
Symptoms: Autism spectrum disorder, Mobility decreased, Pyrexia, Rash
Clinical narrative: Extreme rashing for 6 days, 104 fever consistent for 5 days, unable to move or lift head.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: The patient was given this as a second dose in series, without knowledge that she had already had her second dose of MCV4 two months prior at a Clinic.  Notes do not reflect any knowledge of this by the provider, any conveyance of this history by the family or patient, or any records sent by the Clinic.  Knowledge of this incident came to light yesterday 11/30/2024 upon reconciliation with the State database.  Provider made it known to the mother of this patient today 12/01/2024.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Fall
Clinical narrative: Patient received vaccine on moms lap. After injection given and bandaid placed patient stood up and watched dad get his vaccine. Upon completion patient leaned on mom and slid to the floor.
Age: 24.0
Sex: M
Vaccine: FLU3
Symptoms: Inflammation, Urticaria
Clinical narrative: Hives and inflammation all over my body.  Had to be on steroids, and antihistamines for 2 weeks. I would flare all day. It started 48 hours after vaccine administration.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous, Rash pruritic, Rash vesicular
Clinical narrative: Chickenpox like rash all over body, itchy and red
Age: 47.0
Sex: M
Vaccine: COVID19, FLU3, PNC20
Symptoms: Acoustic stimulation tests normal, Deafness unilateral, Sudden hearing loss, Tinnitus
Clinical narrative: Sudden hearing loss in right ear.  Strong tinnitus followed by hearing loss.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: The patient came into the pharmacy on 11/30/2024 and stated after the spikevax vaccine, she was experiencing redness, swelling, and itching at the immunization site. She also felt a small lump where the vaccine was given. By 11/30/2024, the itching had gone away and the patient said the symptoms were steadily improving. This is the first time she experienced a reaction like this after a vaccination.  I advised her to contact her primary care office if they symptoms were to get worse or if the itching came back.
Age: 1.0
Sex: M
Vaccine: FLU3, HEPA, MMR, PNC20, VARCEL
Symptoms: Blood culture negative, Chest X-ray normal, Culture urine negative, Echocardiogram normal, Febrile convulsion
Clinical narrative: Redness with papule after injections in left thigh lasted without any other associated signs or symptoms for about 3 weeks. Then developed fever with increasing redness and more papules about 11/14/24. had intercurrent viral symptoms or URI at same time. Had febrile seizure and ED visit with hospitalization for fever and possible cellulitis.
Age: 1.0
Sex: M
Vaccine: FLU3, HEPA, MMR, PNC20, VARCEL
Symptoms: Full blood count abnormal, Inflammatory marker increased, Injection site erythema, Injection site papule, Metabolic function test normal
Clinical narrative: Redness with papule after injections in left thigh lasted without any other associated signs or symptoms for about 3 weeks. Then developed fever with increasing redness and more papules about 11/14/24. had intercurrent viral symptoms or URI at same time. Had febrile seizure and ED visit with hospitalization for fever and possible cellulitis.
Age: 1.0
Sex: M
Vaccine: FLU3, HEPA, MMR, PNC20, VARCEL
Symptoms: Neutropenia, Pyrexia, Thrombocytopenia, Upper respiratory tract infection, Viral infection
Clinical narrative: Redness with papule after injections in left thigh lasted without any other associated signs or symptoms for about 3 weeks. Then developed fever with increasing redness and more papules about 11/14/24. had intercurrent viral symptoms or URI at same time. Had febrile seizure and ED visit with hospitalization for fever and possible cellulitis.
Age: 66.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Myalgia, Neck pain
Clinical narrative: Patient called 2 days after receiving both vaccinations to report arm and neck soreness. Patient states the day after the vaccines his right arm was sore and it was also affecting his neck. He took some naproxen and completed his normal yard work as planned. The next morning his right arm felt better but his left arm was more sore. Pharmacist advised him to continue naproxen to help with muscle soreness.  Patient was informed that muscle soreness is to be expected but should resolve on its own and to call the pharmacy if soreness worsens or does not resolve.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Epistaxis, Vomiting
Clinical narrative: Coughing, vomiting, mild nosebleed., shortness of breath. Reached out to my doctor on 12/1/24 for treatment. Prescribed Alvesco and Albuterol Inhaler and Guafenesin if needed. Outcome pending.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Brain fog, Fatigue, Myalgia, Pyrexia
Clinical narrative: 3 days of around-the-clock fevers, myalgias, fatigue, brain fog, bone pain requiring chronic use of naproxen (440 mg PO BID) and acetaminophen (1000 mg PO Q6H). Previous COVID19 vaccine boosters had similar side effects, but duration has been longer and longer with each booster. Have been receiving boosters annually as medically recommended per CDC and FDA guidelines.
Age: 75.0
Sex: M
Vaccine: PNC20
Symptoms: Rash
Clinical narrative: Upper body rash to chest. back, neck Zyrtecs & arms
Age: 82.0
Sex: M
Vaccine: HEPAB, RSV
Symptoms: Musculoskeletal stiffness
Clinical narrative: Patient complained of overall muscle stiffness in limbs, neck and back after receiving vaccines
Age: 62.0
Sex: F
Vaccine: COVID19, FLU3, RSV
Symptoms: Dizziness, Fatigue, Vomiting
Clinical narrative: Vomiting, dizziness, fatigue
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain, Product administered at inappropriate site
Clinical narrative: Patient came by store on 11/21/2024 and reported that the needle from the vaccine may have hit her bursa because she had been experiencing pain that radiated across her chest from the injection site. She said the dose was given higher in her arm than she was accustomed to. I let the customer know that I would report the details that had been provided, and to have her condition evaluated by a medical professional.  I asked her to provide me with details from any visits or if she starts to experience any other symptoms.
Age: 21.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Pain, Posture abnormal
Clinical narrative: After getting Flu vaccine, patient was sitting on the chair in waiting area. My technician noticed that he felt light headedness and he was slipping out of his chair and onto the floor. Meanwhile I was coming out the counselling room. I helped him to lie down flat on the back with feet elevated. He was conscious, breathing normal and responding correctly to my questions. He was lying down for about 45 minutes, felt better and left after about one and half hour. He was having little bit pain, I asked him to described pain intensity on the scale of 1 to 10, he replied 1.
Age: 65.0
Sex: F
Vaccine: TD
Symptoms: Acoustic stimulation tests abnormal, Deafness neurosensory, Deafness unilateral, Sudden hearing loss, Tinnitus
Clinical narrative: Sudden Sensory Neural Hearing Loss in left ear 12 days after Covid-19 vaccination.  Hearing was completely lost in approximately 6 hour time spa.  Treated by ENT specialist with high dose of oral steroids, followed by 2 rounds of steroid injections directly into eardrum.  No improvement during course of treatment, which took about 3 weeks.  Now am literally deaf in left ear with moderate to high tinnitus in that ear.
Sex: F
Vaccine: UNK
Symptoms: Cough, Dyspnoea, Pyrexia
Clinical narrative: Trouble breathing, horse cough, fever, contagious to other kid and parents
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling of whole right upper arm with pain 1-2/10. Redness and warmth  injection site only.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Allergy to animal, Allergy to plants, Endoscopy, Food allergy
Clinical narrative: I received the Piezer Covid vaccine, after the vaccine I have severe allergies to the following: grasses, trees, dogs, cats, dairy, eggs, gluten
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Gluten sensitivity, Milk allergy, Seasonal allergy, Ultrasound thyroid, X-ray
Clinical narrative: I received the Piezer Covid vaccine, after the vaccine I have severe allergies to the following: grasses, trees, dogs, cats, dairy, eggs, gluten
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Blood test, Brain fog, Chills
Clinical narrative: Pain, soreness, brain fog, confusion, Fatigue o Headache o Muscle pain o Joint pain o Chills
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Fatigue, Headache, Mental impairment
Clinical narrative: Pain, soreness, brain fog, confusion, Fatigue o Headache o Muscle pain o Joint pain o Chills
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: Pain, soreness, brain fog, confusion, Fatigue o Headache o Muscle pain o Joint pain o Chills
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, PNC20
Symptoms: Death, Fatigue
Clinical narrative: Perfectly health 11.5lb baby girl at her 6 Month wellness check at 10am. Passed away at 826pm that evening. Showing signs of tiredness as per usual after a round of vaccines.
Age: 50.0
Sex: F
Vaccine: COVID19, FLU3, VARZOS
Symptoms: Dizziness, Immediate post-injection reaction, Loss of consciousness
Clinical narrative: Patient was given flu and covid and before administering she was breathing fast, looks like she was scared. She was ok with covid & flu and had these before but with shingle right away passed out. got very dizzy but still could say words. We raised her leg and gave her water after 10-15 ' still not good & told us and to let us call EMS finally agreed. They check for all tests and everything was normal. Went after 30.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Asthenia, Erythema, Fatigue, Feeling abnormal, Pruritus
Clinical narrative: injection site itch; injection site swelling; injection site pain; gastrointestinal symptoms; fever; shivering; fatigue; myalgia; interrupted sleep; headache; the vaccine hit her like a truck; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site itching in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included thyroid disorder and gastric disorder. Concomitant products included omeprazole magnesium (Omeprazole) and levothyroxine sodium (Levothyroxine).   On 24-JUL-2024, the patient received the 1st dose of Shingrix (left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site itching (Verbatim: injection site itch), injection site swelling (Verbatim: injection site swelling), injection site pain (Verbatim: injection site pain), gastrointestinal symptom nos (Verbatim: gastrointestinal symptoms), fever (Verbatim: fever), shivering (Verbatim: shivering), fatigue (Verbatim: fatigue), myalgia (Verbatim: myalgia), sleep disturbance (Verbatim: interrupted sleep), headache (Verbatim: headache) and feeling abnormal (Verbatim: the vaccine hit her like a truck). The outcome of the injection site itching was not resolved and the outcome of the injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal were resolved.   It was unknown if the reporter considered the injection site itching, injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal to be related to Shingrix.     It was unknown if the company considered the injection site itching, injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal to be related to Shingrix.   Additional Information: GSK Receipt Date: 01-NOV-2024 The reporter stated that she received Shingrix in her left arm.  The patient concomitant medication included as vitamins (unknown name). The reporter stated that at the injection site she had swelling (size of a charcoal Briquette that encompasses a 4 x 4 area in size), injection site itch, injection site pain, myalgia, fatigue, headache, shivering, fever and gastrointestinal symptoms. The reporter stated that the itch was so severe it interrupted her sleep.  The reporter stated that the vaccine hit her like a truck.  The reporter stated that all adverse reactions resolved approximately one month later except injection site itch.  She was examined by a dermatologist and given a cream to put on the area (unknown name of cream).
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin warm, Swelling, Urticaria
Clinical narrative: injection site itch; injection site swelling; injection site pain; gastrointestinal symptoms; fever; shivering; fatigue; myalgia; interrupted sleep; headache; the vaccine hit her like a truck; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site itching in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included thyroid disorder and gastric disorder. Concomitant products included omeprazole magnesium (Omeprazole) and levothyroxine sodium (Levothyroxine).   On 24-JUL-2024, the patient received the 1st dose of Shingrix (left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site itching (Verbatim: injection site itch), injection site swelling (Verbatim: injection site swelling), injection site pain (Verbatim: injection site pain), gastrointestinal symptom nos (Verbatim: gastrointestinal symptoms), fever (Verbatim: fever), shivering (Verbatim: shivering), fatigue (Verbatim: fatigue), myalgia (Verbatim: myalgia), sleep disturbance (Verbatim: interrupted sleep), headache (Verbatim: headache) and feeling abnormal (Verbatim: the vaccine hit her like a truck). The outcome of the injection site itching was not resolved and the outcome of the injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal were resolved.   It was unknown if the reporter considered the injection site itching, injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal to be related to Shingrix.     It was unknown if the company considered the injection site itching, injection site swelling, injection site pain, gastrointestinal symptom nos, fever, shivering, fatigue, myalgia, sleep disturbance, headache and feeling abnormal to be related to Shingrix.   Additional Information: GSK Receipt Date: 01-NOV-2024 The reporter stated that she received Shingrix in her left arm.  The patient concomitant medication included as vitamins (unknown name). The reporter stated that at the injection site she had swelling (size of a charcoal Briquette that encompasses a 4 x 4 area in size), injection site itch, injection site pain, myalgia, fatigue, headache, shivering, fever and gastrointestinal symptoms. The reporter stated that the itch was so severe it interrupted her sleep.  The reporter stated that the vaccine hit her like a truck.  The reporter stated that all adverse reactions resolved approximately one month later except injection site itch.  She was examined by a dermatologist and given a cream to put on the area (unknown name of cream).